The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(4-chlorobenzyl)-1H-indole-2-carbonyl)-N-(2-(pyridin-4-yl)ethyl)azepane-4-carboxamide ID: ALA4863446
PubChem CID: 164625475
Max Phase: Preclinical
Molecular Formula: C30H31ClN4O2
Molecular Weight: 515.06
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCc1ccncc1)C1CCCN(C(=O)c2cc3ccccc3n2Cc2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C30H31ClN4O2/c31-26-9-7-23(8-10-26)21-35-27-6-2-1-4-25(27)20-28(35)30(37)34-18-3-5-24(14-19-34)29(36)33-17-13-22-11-15-32-16-12-22/h1-2,4,6-12,15-16,20,24H,3,5,13-14,17-19,21H2,(H,33,36)
Standard InChI Key: WROBQZFVTGWOTL-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
35.3914 -13.7044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0018 -14.0520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3824 -13.1570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1644 -10.3141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1632 -11.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8795 -11.5579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5973 -11.1420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5944 -10.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8776 -9.9030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3096 -11.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3109 -12.3818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7316 -13.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9841 -12.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9055 -13.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6526 -12.8674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8497 -12.6987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2989 -13.3115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5565 -14.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3588 -14.2605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4484 -9.9034 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.7689 -12.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9368 -11.7969 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.1397 -12.8424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8623 -13.2440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1529 -13.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6274 -14.6218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4505 -14.6658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7957 -14.2791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9940 -15.0807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.1961 -13.8943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7572 -13.2897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5619 -13.4753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8008 -14.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6048 -14.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1668 -13.8502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9235 -13.0565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1201 -12.8703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 10 1 0
10 11 1 0
11 15 1 0
14 12 1 0
12 13 2 0
13 11 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
4 20 1 0
13 21 1 0
21 22 2 0
21 3 1 0
3 23 1 0
23 24 1 0
3 25 1 0
24 2 1 0
25 26 1 0
2 27 1 0
26 27 1 0
2 28 1 0
28 29 2 0
28 1 1 0
1 30 1 0
30 31 1 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.06Molecular Weight (Monoisotopic): 514.2136AlogP: 5.34#Rotatable Bonds: 7Polar Surface Area: 67.23Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 5.05CX LogP: 4.57CX LogD: 4.57Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.36Np Likeness Score: -1.61
References 1. Barraza SJ, Sindac JA, Dobry CJ, Delekta PC, Lee PH, Miller DJ, Larsen SD.. (2021) Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore., 46 [PMID:34098081 ] [10.1016/j.bmcl.2021.128171 ]